Annual Financials for Global Medical REIT Inc.
Fiscal year is January-December. All values USD millions. |
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Sales/Revenue |
30.34M | 53.19M | 70.73M | 93.73M | 109.57M | |
Total Investment Income |
- | - | - | - | - | |
Sundry Revenue/Income |
121,000 | 54,000 | 211,000 | 212,000 | (6.23M) | |
Trading Account Income |
- | - | - | - | - | |
Trust Income, Commissions & Fees |
- | - | - | - | - | |
Commission & Fee Income |
- | - | - | - | - | |
Sales Growth |
- | 75.30% | 32.96% | 32.53% | 16.90% | |
Total Expense |
23M | 31.33M | 43.7M | 77.51M | 78.97M | |
Total Interest Expense |
6.21M | 13.01M | 15.24M | 12.38M | 13.33M | |
Depreciation & Amortization Expense |
10M | 17.27M | 24.67M | 36.31M | 46.88M | |
Other Operating Expense |
4.32M | 3.05M | 3.61M | 5.68M | 5.96M | |
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Operating Income |
7.35M | 21.86M | 27.03M | 16.22M | 30.61M | |
Operating Income Growth |
- | 197.51% | 23.63% | -39.98% | 88.69% | |
Non-Operating Income (Expense) |
- | 7.48M | (969,000) | (4.91M) | 1.07M | |
Non-Operating Interest Income |
- | - | - | - | - | |
Miscellaneous Non Operating Expense |
- | 7.48M | (969,000) | (4.91M) | 1.07M | |
Equity in Affiliates (Pretax) |
- | - | - | - | - | |
Unusual Expense |
- | - | - | - | - | |
Pretax Income |
(87,000) | 14.56M | 9.55M | (2.46M) | 18.34M | |
Pretax Income Growth |
- | 16,836.78% | -34.39% | -125.75% | 845.61% | |
Pretax Margin |
- | - | - | - | 16.74% | NA |
Income Taxes |
- | - | - | - | - | |
Income Tax - Current - Domestic |
- | - | - | - | - | |
Income Tax - Current - Foreign |
- | - | - | - | - | |
Income Tax - Deferred - Domestic |
- | - | - | - | - | |
Income Tax - Deferred - Foreign |
- | - | - | - | - | |
Income Tax Credits |
- | - | - | - | - | |
Equity in Affiliates |
- | - | - | - | - | |
Other After Tax Income (Expense) |
- | - | - | - | - | |
Consolidated Net Income |
(87,000) | 14.56M | 9.55M | (2.46M) | 18.34M | |
Minority Interest Expense |
(49,000) | 1.07M | 354,000 | (574,000) | 720,000 | |
Net Income |
(38,000) | 13.49M | 9.2M | (1.89M) | 17.62M | |
Net Income Growth |
- | 35,600.00% | -31.80% | -120.50% | 1,034.36% | |
Net Margin |
- | - | - | - | 16.08% | NA |
Extraordinaries & Discontinued Operations |
- | - | - | - | - | |
Extra Items & Gain/Loss Sale Of Assets |
- | - | - | - | - | |
Cumulative Effect - Accounting Chg |
- | - | - | - | - | |
Discontinued Operations |
- | - | - | - | - | |
Net Income After Extraordinaries |
- | - | - | - | - | |
Preferred Dividends |
1.71M | 5.82M | 5.82M | 5.82M | 5.82M | |
Net Income Available to Common |
(1.75M) | 7.67M | 3.38M | (7.71M) | 11.8M | |
EPS (Basic) |
(0.09) | 0.35 | 0.10 | (0.17) | 0.19 | |
EPS (Basic) - Growth |
- | 490.82% | -71.12% | -266.17% | 216.18% | |
Basic Shares Outstanding |
19.62M | 21.97M | 33.87M | 46.26M | 60.64M | |
EPS (Diluted) |
(0.09) | 0.35 | 0.10 | (0.17) | 0.19 | |
EPS (Diluted) Growth |
- | 490.82% | -71.12% | -266.17% | 216.18% | |
Diluted Shares Outstanding |
19.62M | 21.97M | 33.87M | 46.26M | 60.64M | |